相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
Lymphocyte-mediated neuroprotection in in vitro models of excitotoxicity involves astrocytic activation and the inhibition of MAP kinase signalling pathways
Rajeev Shrestha et al.
NEUROPHARMACOLOGY (2014)
KRP-203, Sphingosine 1-Phosphate Receptor Type 1 Agonist, Ameliorates Atherosclerosis in LDL-R-/- Mice
Francesco Poti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Pathway specific modulation of S1P1 receptor signalling in rat and human astrocytes
Luke M. Healy et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Fingolimod phosphate promotes the neuroprotective effects of microglia
Hiromi Noda et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive Tregs Involves IL-6-Mediated Signaling
Anya Schneider et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
The role of sphingosine 1-phosphate receptors in the treatment of demyelinating diseases
Adam J. Pritchard et al.
FUTURE NEUROLOGY (2013)
S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures
Graham K. Sheridan et al.
GLIA (2012)
Oligodendrocyte Precursor Cell Transplantation into Organotypic Cerebellar Shiverer Slices: A Model to Study Myelination and Myelin Maintenance
Jenea M. Bin et al.
PLOS ONE (2012)
CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system
Carolin Prodinger et al.
ACTA NEUROPATHOLOGICA (2011)
FTY720-Induced Conversion of Conventional Foxp3-CD4+ T Cells to Foxp3+ Regulatory T Cells in NOD Mice
Yun Sun et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2011)
Interactions between oligodendrocyte precursors control the onset of CNS myelination
Yan Yang et al.
DEVELOPMENTAL BIOLOGY (2011)
Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model
Hye Jung Kim et al.
FASEB JOURNAL (2011)
Engagement of S1P1-degradative mechanisms leads to vascular leak in mice
Myat Lin Oo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Fingolimod modulates microglial activation to augment markers of remyelination
Samuel J. Jackson et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo
Yinghui Hu et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2011)
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
Ji Woong Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices
Veronique E. Miron et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis
Aine C. Murphy et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
FTY720, a sphingosine 1-phosphate receptor modulator, inhibits CD1d-restricted NKT cells by suppressing cytokine production but not migration
Su Jin Hwang et al.
LABORATORY INVESTIGATION (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The Sphingosine 1-Phosphate Receptor Agonist FTY720 Potently Inhibits Regulatory T Cell Proliferation In Vitro and In Vivo
Anna Maria Wolf et al.
JOURNAL OF IMMUNOLOGY (2009)
Accumulation of Fingolimod (FTY720) in Lymphoid Tissues Contributes to Prolonged Efficacy
Sven-Christian Sensken et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors
Florian Mullershausen et al.
NATURE CHEMICAL BIOLOGY (2009)
In situ activation of antigen-specific CD8+ T cells in the presence of antigen in organotypic brain slices
Changying Ling et al.
JOURNAL OF IMMUNOLOGY (2008)
Anti-inflammatory effects of FTY720 against viral-induced immunopathology:: Role of drug-induced conversion of T cells to become Foxp3+ regulators
Sharvan Sehrawat et al.
JOURNAL OF IMMUNOLOGY (2008)
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease
Melissa K. Mccoy et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis
Kumlesh K. Dev et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Cutting edge: Alternative signalin of Th17 cell development by sphingosine 1-phosphate
Jia-Jun Liao et al.
JOURNAL OF IMMUNOLOGY (2007)
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubipuitinylation and proteasomal degradation of the receptor
Myat Lin Oo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells
Carolin Daniel et al.
JOURNAL OF IMMUNOLOGY (2007)
In vitro generation of CD4+CD25+regulatory cells from murine naive T cells
Massimo C. Fantini et al.
NATURE PROTOCOLS (2007)
IL-6 and IL-8 release is mediated via multiple signaling pathways after stimulating dendritic cells with lysophospholipids
Devrim Oz-Arslan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720
B Zemann et al.
BLOOD (2006)
Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720
Y Kharel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Association between peripheral IFN-γ producing CD8+ T-cells and disability score in relapsing-remitting multiple sclerosis
J Sepulcre et al.
CYTOKINE (2005)
Edg8/S1P5: An oligodendroglial receptor with dual function on process retraction and cell survival
C Jaillard et al.
JOURNAL OF NEUROSCIENCE (2005)
The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells
H Müller et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
M Matloubian et al.
NATURE (2004)
Biologically active sphingolipids in cancer pathogenesis and treatment
B Ogretmen et al.
NATURE REVIEWS CANCER (2004)
Transduction of multiple effects of sphingosine 1-phosphate (S1P) on T cell functions by the S1P1 G protein-coupled receptor
G Dorsam et al.
JOURNAL OF IMMUNOLOGY (2003)
Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis
E Bettelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
The immune modulator FTY720 targets sphingosine 1-phosphate receptors
V Brinkmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists
S Mandala et al.
SCIENCE (2002)
Interferon-gamma-induced calcium influx in T lymphocytes of multiple sclerosis and rheumatoid arthritis patients: a complementary mechanism for T cell activation?
M Buntinx et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Onset of multiple sclerosis associated with anti-TNF therapy
NL Sicotte et al.
NEUROLOGY (2001)
Characterization of a novel sphingosine 1-phosphate receptor, Edg-8
DS Im et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes
F Aloisi et al.
IMMUNOLOGY TODAY (2000)
Edg-6 as a putative sphingosine 1-phosphate receptor coupling to Ca2+ signaling pathway
Y Yamazaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
